Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium

Summary

Harbour BioMed and Sinopharm announced a strategic collaboration to establish an innovation R&D consortium focused on antibody therapeutics in immunology, oncology and other therapeutic areas.